Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliu

Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliu

Item

http://www.wikidata.org/entity/Q31155203

Q31155203

about

Ruthenium metalation of proteins: the X-ray structure of the complex formed between NAMI-A and hen egg white lysozyme Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells.Comparison of KP1019 and NAMI-A in tumour-mimetic environments.Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion.The use of X-ray absorption and synchrotron based micro-X-ray fluorescence spectroscopy to investigate anti-cancer metal compounds in vivo and in vitro.Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential.Poly(lactic acid) nanoparticles of the lead anticancer ruthenium compound KP1019 and its surfactant-mediated activation.X-ray fluorescence imaging of single human cancer cells reveals that the N-heterocyclic ligands of iodinated analogues of ruthenium anticancer drugs remain coordinated after cellular uptake.Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells.En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2]Influence of ascorbic acid on the activity of the investigational anticancer drug KP1019.Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cells Albumin binding and ligand-exchange processes of the Ru(III) anticancer agent NAMI-A and its bis-DMSO analogue determined by ENDOR spectroscopy.Electronic State of Sodium trans-[Tetrachloridobis(1H-indazole)ruthenate(III)] (NKP-1339) in Tumor, Liver and Kidney Tissue of a SW480-bearing Mouse.Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339.Inhibitory effects of NAMI-A-like ruthenium complexes on prion neuropeptide fibril formation.X-ray absorption near edge structure spectroscopy to resolve the in vivo chemistry of the redox-active indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019).EPR as a probe of the intracellular speciation of ruthenium(III) anticancer compounds.Anti-cancer drug KP1019 modulates epigenetics and induces DNA damage response in Saccharomyces cerevisiae.A study of the interactions between carboplatin and blood plasma proteins using size exclusion chromatography coupled to inductively coupled plasma mass spectrometry.A systematic assessment of chemical, genetic, and epigenetic factors influencing the activity of anticancer drug KP1019 (FFC14A).Water-soluble platinum phthalocyanines as potential antitumor agents.

P2860

Q27689147-2041C196-053A-4B69-B4BB-3F8A8DB09C68 Q36032742-908F7EA9-B6DB-42F4-B10E-CE7B49E6A9A8 Q36086603-21CFA017-6763-496E-B201-B62E022A0CA3 Q37356641-3D704DED-D6A2-4002-9E7A-9151C79DD611 Q38096196-8B2019F3-3DA7-4E3E-B224-479E673DBC94 Q38941379-4752D072-9DDC-4A84-BB19-E2046B07BD9F Q39069440-B35EA13A-3DCD-4C51-B26D-CA9DA71E999B Q39110547-73EB61FF-EDB0-4EE3-B881-2A31DE603676 Q39294174-F90E5CA2-B486-4BE2-A4E3-A52F3B5333BB Q39510416-A42F19BC-E09F-4D24-B4E4-70AC9BFDF0C6 Q39517558-7F7C0791-5E77-444B-A3D8-1E71E8AF7AC0 Q39900189-57466C41-5D7D-4F9D-99B9-5C1199D1142D Q40737623-97786574-C848-4918-AA2E-8077364C91F1 Q41883625-C549EC65-5F51-4737-A28B-0B18EB746570 Q42040747-2A3A1D77-9ED3-4A8B-9D48-DDCD8CDEC945 Q42174365-269FC611-D6DF-42F9-A07C-F4F9E74FF7C3 Q43242098-9B0D136C-1D2D-466F-B433-D345713E62E9 Q43811304-61695FFA-F1F3-4043-B2B7-FB81A3BD5369 Q44384757-FBBADE44-3534-489C-A3ED-B000FC44F993 Q47298399-CF06D731-34E6-4180-9AE3-F72FA35AD675 Q49517494-EDB8565D-5D38-4040-9571-D81DB29F9145 Q50223915-CF90DB9E-62A0-4D7C-8DE6-032A215FAF97

P2860

Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliu

Item

http://www.wikidata.org/entity/Q31155203

description

1996 nî lūn-bûn

@nan

1996 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu